PRKD1 and congenital heart disease: Studies from Sifrim et al. (Sifrim et al., 2016) and more recently Alter et al. (Alter et al., 2020) identify heterozygous de novo missense mutations in PRKD1 in five patients with syndromic congenital heart disease.